Arcadia Investment Advisors LLC Bristol Myers Squibb CO Transaction History

Arcadia Investment Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Dec 19, 2024	SELL	$59.17 - $69.31 $946 - $1,108	-16 Closed	0 $0
Q2 2021 Dec 19, 2024	BUY	$61.91 - $67.42 $990 - $1,078	16 New	16 $1.07 Million
Q1 2021 Dec 19, 2024	SELL	$59.34 - $66.74 $42,546 - $47,852	-717 Closed	0 $0
Q4 2020 Dec 19, 2024	SELL	$57.74 - $65.43 $47,115 - $53,390	-816 Reduced 53.23%	717 $44.5 Million
Q3 2020 Dec 19, 2024	BUY	$57.43 - $63.64 $7,638 - $8,464	133 Added 9.5%	1,533 $92.4 Million
Q4 2019 Dec 19, 2024	BUY	$49.21 - $64.19 $68,894 - $89,866	1,400 New	1,400 $89.9 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Arcadia Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Arcadia Investment Advisors LLC with notifications on news.